In breast cancer, ATRA-liganded RAR/RXR heterodimers are purported to mediate growth inhibition, whereas the PPARβ-δ/RXR heterodimer is believed to induce proliferation [13, 17]. The gene discussed is RARA; the disease is breast carcinoma.